Young-Jin Kim | Structural Biology | Best Researcher Award

Dr. Young-Jin Kim | Structural Biology | Best Researcher Award

Pohang University of Science and Technology (POSTECH) | South Korea

Author Profiles

Scopus

Orcid ID

Early Academic Pursuits

Dr. Young-jin Kim’s academic journey began with a strong foundation in chemistry, completing a Bachelor of Science at Sungkyunkwan University, followed by a Master’s and Ph.D. in Chemistry at KAIST, Korea. His early research pursuits were rooted in structural studies related to immunity, where he contributed significantly to understanding how structural integrity impacts infectious disease progression. These formative years not only provided rigorous training in molecular and structural biology but also shaped his focus toward the intricate dynamics of protein structures.

Professional Endeavors

Following his doctoral studies, Dr. Kim pursued postdoctoral training at KAIST and later at the prestigious Rockefeller University, USA, under the mentorship of renowned structural biologists. These experiences expanded his expertise in advanced structural biology techniques such as X-ray crystallography and cryo-electron microscopy (Cryo-EM). Currently, as an Assistant Professor in the Department of Life Sciences at Pohang University of Science and Technology (POSTECH), Dr. Kim leads a research group investigating membrane protein structures and their physiological relevance.

Contributions and Research Focus

Dr. Kim’s research has centered on unraveling the mechanisms of ABC and SLC transporters—membrane proteins that play pivotal roles in drug resistance and cellular homeostasis. Notably, his groundbreaking discovery of the occluded conformation of human P-glycoprotein was a first in the field, advancing global understanding of drug efflux mechanisms. His ongoing projects include exploring the structural basis of multidrug resistance and elucidating plant circadian clock proteins through Cryo-EM and protein engineering approaches. Recent accomplishments include identifying the human OAT1 structure and its chloride-dependent drug transport mechanism, published in Structure (2025).

Impact and Influence

Dr. Kim’s work has had profound implications for both fundamental science and translational medicine. His structural studies on membrane transporters provide critical insights into drug design, particularly for overcoming multidrug resistance in cancer and infectious diseases. Beyond the laboratory, Dr. Kim has been an active contributor to the scientific community, serving as a committee member for the Women’s Life Science and Technology Forum and frequently delivering invited talks at prestigious conferences, workshops, and universities.

Academic Citations and Recognition

Dr. Kim’s contributions are reflected in his invited speaker roles across international symposia, including EASMB 2024, Soongsil University, Yeungnam University, and multiple workshops. His research achievements have been consistently recognized with awards, such as poster awards at NYKB and KOSUA meetings, a Hot Structure Poster Award by the Korean Society for Molecular and Cellular Biology, and presentation honors as early as his graduate years. These accolades underscore his long-standing excellence and sustained trajectory of impactful scholarship.

Legacy and Future Contributions

Looking ahead, Dr. Kim is poised to further shape the field of structural biology by pushing the frontiers of Cryo-EM to decode complex protein dynamics relevant to both human health and plant biology. His interdisciplinary approach—bridging structural biology, life sciences, and protein engineering—positions him to contribute not only to academic advancements but also to the development of innovative therapeutic strategies. His legacy will be defined by groundbreaking discoveries in membrane protein biology and by mentoring the next generation of structural biologists at POSTECH.

Conclusion

Dr. Young-jin Kim exemplifies the qualities of a visionary researcher whose academic rigor, innovative discoveries, and global contributions have positioned him as a leader in structural biology. His early academic excellence, groundbreaking research on membrane transporters, and dedication to advancing both science and mentorship make him an outstanding candidate for recognition such as the Best Researcher Award. His trajectory promises enduring influence in science and medicine, reinforcing his role as a pioneer in the field.

Notable Publications

"Cryo-EM structures of human OAT1 reveal drug binding and inhibition mechanisms

  • Author: Hyung-Min Jeon; Jisung Eun; Kelly H. Kim; Youngjin Kim
  • Journal: Structure
  • Year: 2025

"Structural Basis for Activation of the Heterodimeric GABAB Receptor

  • Author: Kim Y, Jeong E, Jeong JH, Kim Y, Cho Y
  • Journal: Journal of Molecular Biology
  • Year: 2020

"Structural basis of the fanconi anemia-associated mutations within the FANCA and FANCG complex

  • Author: Lee, SG. Kim, HS. Yang, J. Shin, J. Kim, Y. Kim, J. Scharer, O. D. Kim, Y. Yeo, JE. Kim, HM. Cho, Y
  • Journal: Nucleic Acids Research
  • Year: 2020

"The application of helix fusion methods in structural biology

  • Author: Na-Young Kwon; Youngjin Kim; Jie-Oh Lee
  • Journal: Current Opinion in Structural Biology
  • Year: 2020

"Attachment of flagellin enhances the immunostimulatory activity of a hemagglutinin-ferritin nano-cage

  • Author: Lee, EB, Jeon, HM. Kim, CU, Park, SM, Cho, G, Kim, HJ, Kim, Y, Kim, DJ, Kim, Y. S., Lee, H, Lee
  • Journal: Nanomedicine: Nanotechnology, Biology and Medicine
  • Year: 2024

Rishi Pandey | Biological Networks | Best Researcher Award

Dr. Rishi Pandey | Biological Networks | Best Researcher Award

Western Sydney University | Australia

Author Profile

Scopus

Google Scholar

EARLY ACADEMIC PURSUITS

Rishi Pandey began his journey in the field of science with a deep-rooted passion for biochemistry and analytical chemistry. His foundational academic experiences were marked by a strong inclination toward research and laboratory-based innovations. He cultivated his scientific rigor early, focusing on the integration of chemical principles with biological applications, which laid the groundwork for his later success in biosensor development and molecular diagnostics.

PROFESSIONAL ENDEAVORS

With over a decade of impactful professional experience, Rishi Pandey has held key roles across academia, government-funded research institutions, and biotech start-ups. Currently serving as the Research Manager at the School of Medicine, Western Sydney University, he leads the Mass Spectrometry and Next-Gen Sequencing research platforms. He has also held pivotal roles at Eurofins NZ, Manuka Health Ltd., and Eve Health Labs, where he managed high-value analytical projects, developed cutting-edge testing methods, and led cross-functional teams. His career reflects a strategic balance between scientific depth and operational leadership.

CONTRIBUTIONS AND RESEARCH FOCUS ON BIOLOGICAL NETWORK

Rishi Pandey's research interests span analytical chemistry, proteomics, biosensor development, molecular diagnostics, and the application of machine learning for scientific innovation. He is notably recognized for developing an electrochemical biosensor device for point-of-contact drug testing-an innovation that earned him the 2021 KiwiNet Emerging Innovator Award. His leadership in engineering protein-based antiviral candidates and establishing platforms for forensic identification and gut health metabolomics have led to several successful translational research outcomes. He also contributed to the establishment of analytical laboratories and the integration of LEAN and Agile methodologies for efficient scientific workflows.

IMPACT AND INFLUENCE

Rishi Pandey has significantly influenced the scientific and industrial communities by bridging the gap between academic research and commercial science. His leadership has accelerated the development of cost-effective diagnostic and testing solutions, saving organizations hundreds of thousands of dollars. His training programs for postgraduate students and researchers in advanced analytical techniques have elevated the skill sets of future scientists. Moreover, his collaborative partnerships with research institutes in Australia, New Zealand, and the U.S. have facilitated global innovation in biosciences.

ACADEMIC CITES

While specific citation metrics are not disclosed here, Rishi Pandey’s body of work in proteomics, analytical method development, and biosensors contributes to high-impact fields such as forensic science, public health diagnostics, and functional food analytics. His contributions have been instrumental in fostering impactful publications and enabling the development of competitive research proposals within academic and industrial settings.

LEGACY AND FUTURE CONTRIBUTIONS

Rishi Pandey’s legacy is one of translational excellence, scientific curiosity, and strategic leadership. His continued efforts to fuse biochemical research with AI-driven data mining and diagnostics position him as a thought leader in the emerging landscape of precision medicine and bioanalytical technology. Looking forward, his contributions are expected to expand the accessibility of rapid diagnostics, foster global research collaborations, and inspire a new generation of biochemists focused on science commercialization for societal benefit.

OTHER IMPORTANT HIGHLIGHTS

  • Recognized by KiwiNet as an Emerging Innovator for proteomics and biosensor innovations.

  • Spearheaded commercial laboratory growth at Eve Health Labs to exceed $350,000 in annual revenue.

  • Developed and validated critical testing methodologies for high-value nutraceuticals and food safety at Eurofins NZ and Manuka Health Ltd.

  • Expertise spans across analytical instruments such as Thermo Orbitrap, SCIEX, Waters LCMS/MS, and Bruker Q-TOF, contributing to robust quality and analytical assurance.

  • Played a key role in industry-academia interface, fostering cross-border collaborations and industry-aligned research deliverables.

NOTABLE PUBLICATIONS

"Electrochemical Aptamer-Based Biosensors for Cocaine Detection in Human Saliva: Exploring Matrix Interference

  • Author: Y Liu, R Pandey, MJ McCarthy, O Raymond
  • Journal: Analytical Chemistry
  • Year: 2025

"Nanoparticle based antigen detection of norovirus in human faecal samples: A proof-of-concept study

  • Author: R Pandey, P Gyawali, MAT Blaskovich, KC Sanjaya
  • Journal: Nanoparticle based antigen detection of norovirus in human faecal samples: A proof-of-concept study
  • Year: 2025

"UHPLC and Computational Studies of Chemical Constituents Derived from Myrica esculenta against NADPH Oxidase 2 (NOX2) Protein

  • Author: AR Pandey, WA Ansari, P Maurya, H Aslam, RR Pandey, DP Mishra
  • Journal: ChemistrySelect
  • Year: 2025

"Single-Use Electrochemical Aptamer-Based Sensors for Calibration-Free Measurements in Human Saliva via Dual-Frequency Approaches: Prospects and Challenges

  • Author: Y Liu, R Pandey, MJ McCarthy, O Raymond
  • Journal: Analytical Chemistry
  • Year: 2025

"Hydrochar from agrowastes: a low-cost adsorbent for environmental application

  • Author: RR Pandey, AR Pandey, AK Tripathi, J Kumar
  • Journal: Role of Green Chemistry
  • Year: 2024